Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies

Neurology

Volumn 81, Issue 20, 2013, Pages 1741-1745

  Oda, Haruhiko ^a   Ishii, Kazunari ^b,c   Terashima, Akira ^a   Shimada, Ken Ichi ^a   Yamane, Yumiko ^a   Kawasaki, Ryota ^b   Ohkawa, Shingo ^a  

^a Hyogo Brain and Heart Center   (Japan)

^b Kinki University Faculty of Medicine ^*  (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CORPUS STRIATUM; DIFFUSE LEWY BODY DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MYOCARDIAL PERFUSION IMAGING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL HALLUCINATION;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; INOSINE MONOPHOSPHATE; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MYOCARDIAL PERFUSION IMAGING; NEUROPSYCHOLOGICAL TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888273255     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000435553.67953.81     Document Type: Article

References (21)

1. Samuel W, Caligiuri M, Galasko D, et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 2000;15:794-802.
2. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
3. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
4. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
5. Yoshita M, Taki J, Yokoyama K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006;66:1850-1854.
6. Treglia G, Cason E, Cortelli P, et al. Iodine-123metaiodobenzylguanidine scintigraphy and iodine-123Ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging Epub 2012 Nov 19.
7. Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004;62:181-187.
8. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53: 413-416.
9. Defebvre LJ, Leduc V, Duhamel A, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999;40:956-962.
10. Colloby SJ, Fenwick JD,Williams ED, et al. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002;29:615-622.
11. Ishii K, Hosaka K, Mori T, Mori E. Comparison of FDGPET and IMP-SPECT in patients with dementia with Lewy bodies. Ann Nucl Med 2004;18:447-451.
12. Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with Lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 2012;22:111-117.
13. Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clin Neurol Neurosurg 2011;113:823-829.
14. Nagamachi S, Wakamatsu H, Kiyohara S, et al. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy. Ann Nucl Med 2008;22:557-564.
15. Oide T, Tokuda T, Momose M, et al. Usefulness of [123I] metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies. Intern Med 2003;42: 686-690.
16. Tateno F, Sakakibara R, Kishi M, et al. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord 2011;17:395-397.
17. Hanyu H, Shimizu S, Hirao K, et al. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006;33:248-253.
18. Tateno M, Kobayashi S, Shirasaka T, et al. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 2008;26: 453-457.
19. Inui Y, Toyama H, Manabe Y, et al. Evaluation of probable or possible dementia with Lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT. J Nucl Med 2007;48:1641-1650.
20. Orimo S, Amino T, Itoh Y, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 2005;109: 583-588.
21. Treglia G, Cason E, Giordano A, Fagioli G. Abnormal striatal dopaminergic and cardiac sympathetic imaging in dementia with Lewy bodies: two sides of the same coin. Parkinsonism Relat Disord 2012;18:707-708.